North American Educational Forum on Lymphoma

October 15 – 17, 2021 - 1pm ET on October 15th and close at 5pm ET on October 17th


October 15 – 17, 2021







2021 Educational Forum Agenda Planning

Friday, October 15, 2021

1pm ET

Platform Opens (open for entire weekend)

2:00pm – 3:00pm

Introductory Breakouts (choose one)

  • Lymphoma Overview for Newly Diagnosed Patients and Caregivers –Jacob Soumerai, MD, Massachusetts General Hospital
  • Lymphoma Survivorship – Priyanka Pophali, MD, University of Wisconsin
  • Relapsed/Refractory – How to Cope When your Lymphoma Returns?Jennifer Amengual, MD, Columbia University Medical Center
3:30pm – 4:30pm

Healthy Ways to Interact with the Internet/Social Media

  • Giselle Perez Lougee, PhD, Massachusetts General Hospital

Saturday, October 16, 2021

10:30 AM – 10:45 AM

LRF Overview and Welcome

10:45 AM

What to Know About Clinical Trials

  • Laurie Sehn, MD, British Columbia Cancer Agency
11:15 AM

Update on COVID-19

  • John Leonard, MD, Weill Cornell Medicine/New York Presbyterian
11:45 AM

30 minute Q&A with both speakers

12:15 PM – 12:30 PM

Move Around and Stretch!

12:30 PM – 1:30 PM

Disease Specific Breakout Sessions – B-Cell Lymphomas (choose one)

  • Burkitt Lymphoma – Adam Olszewski, MD, Lifespan Cancer Institute at Rhode Island Hospital
  • Primary Central Nervous System Lymphoma – Lakshmi Nayak, MD, Dana-Farber Cancer Institute
  • CLL/SLL – Danielle Brander, MD, Duke University
  • Diffuse Large B-Cell Lymphoma and Other Aggressive B-Cell Lymphomas (Double and Triple Hit) Narendranath Epperla, MD, MS, Ohio State University Comprehensive Cancer Center
  • Splenic Marginal Zone Extranodal MALT and Nodal Marginal Zone Lymphoma - Tycel Philips, MD, University of Michigan
  • Follicular Lymphoma – Kami Maddocks, MD, Ohio State University
  • Hodgkin Lymphoma – Matthew Mei, MD, City of Hope
  • Mantle Cell Lymphoma – Ann LaCasce, MD, Dana-Farber Cancer Institute
  • Waldenstrom Macroglobulinemia – Shuo Ma, MD, Northwestern University
  • LRF Staff Overview of T-Cell Resources
2:00 PM – 3:00 PM

Patients and Physicians Panel Discussion – Ed Forum Chairs and LRF Ambassadors

3:15 PM – 4:15 PM

Nutrition: Fuel Your Fight

  • Hannah Manella, MS, RD, CSO, LDN. Rush University Medical Center
4:30 PM – 5:30 PM

Disease Specific Breakout Sessions – T-Cell Lymphomas (choose one)

  • Anaplastic Large Cell Lymphoma – Francine Foss, MD, Yale University
  • Angioimmunoblastic T-Cell Lymphoma – Neha Mehta-Shah, MD, University of Washington in St. Louis
  • Cutaneous T-Cell Lymphomas – Pamela Allen, MD, Emory University
  • Peripheral T-Cell Lymphoma NOS – Pierluigi Porcu, MD, Jefferson University Hospitals
  • Rare T-Cell Lymphomas – Adult T-Cell Leukemia/Lymphoma, Enteropathy-Type T-Cell
  • Lymphoma, Hepatosplenic Gamma-Delta T-Cell Lymphoma and Nasal NK/T-Cell
  • Lymphomas – Steve Horwitz, MD, Memorial Sloan Kettering
  • LRF Staff Overview of B-Cell Resources

Sunday, October 17, 2021

10:30 AM – 11:30 AM

Mindfulness and Meditation

11:45 AM – 12:45 PM

Special Lymphoma Breakout Topics (choose one)

  • Advanced Diagnostic and Biomarker Testing for Lymphoma – Eric Hsi, MD, Wakeforest University
  • Adolescent and Young Adult Lymphoma and Survivorship – Kara Kelly, MD, Roswell Park Comprehensive Cancer Center
  • Imaging and Scans: Why do I need it? – Carrie Thompson, MD, Mayo Clinic
  • Minimal Residual Disease (MRD) – Matthew Davids, MD, Dana-Farber Cancer Institute
  • Oral Agents – Craig Portell, MD, University of Virginia
  • What to do When Lymphoma Transforms and What that Means – Loretta Nastoupil, MD, MD Anderson Cancer Center
1:15 PM – 2:15 PM

Living with Lymphoma Breakouts (choose one)

  • Caregivers Support Group – Molly Williamson, LCSW, Mayo Clinic, Arizona
  • Managing Treatment Side Effects - Chemotherapy and Transplant– Sharyn Kurtz, PA-C, Dana-Farber Cancer Institute
  • Health Insurance and Employment – Avoiding Financial Toxicity and Hardships – Joanna Morales, Esq. Triage Cancer
2:30 PM – 3:45 PM

Immunotherapy and CAR T Cell Therapy

  • Alex Herrera, MD, City of Hope and Bruce Cheson, MD, Johns Hopkins
4:00 PM – 5:00 PM

Relapsed/Refractory Breakouts (choose one)

  • CLL/SLL –Jacqueline Barrientos, MD, Northwell Health
  • DLBCL – Jennifer Crombie, MD, Dana-Farber Cancer Institute
  • Hodgkin– Reid Merryman, MD, Dana-Farber Cancer Institute
  • Follicular– Paolo Strati, MD, MD Anderson Cancer Center
  • Mantle Cell Lymphoma – Jonathan Cohen, MD, Emory University
5:00 PM

Closing Remarks

National Presenting Supporter




National Platinum Supporter




National Gold Supporters




National Silver Supporters




National Bronze Supporters